Evaluation of increased bioavailability of tacrolimus in rats with experimental renal dysfunction

Journal of Pharmacy and Pharmacology

Volumn 54, Issue 1, 2002, Pages 65-70

  Okabe, H ^a   Yano, I ^a   Hashimoto, Y ^b   Saito, H ^a   Inui, K I ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; TACROLIMUS;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG INFUSION; DRUG METABOLISM; DRUG SOLUBILITY; EXPERIMENTAL MODEL; EXPERIMENTATION; INTESTINE ABSORPTION; INTESTINE LOOP; KIDNEY CLEARANCE; KIDNEY DYSFUNCTION; LIVER METABOLISM; MALE; METABOLIC RATE; NONHUMAN; NONLINEAR SYSTEM; PORTAL VEIN; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOLOGICAL AVAILABILITY; CISPLATIN; IMMUNOSUPPRESSIVE AGENTS; INTESTINAL ABSORPTION; INTESTINES; KIDNEY FAILURE, ACUTE; LIVER; MALE; RATS; RATS, WISTAR; TACROLIMUS; TISSUE DISTRIBUTION;

EID: 0036159876     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357021771931     Document Type: Article

References (24)

1. Influences of renal failure on the hepatic clearance of bufuralol in man
2. Intestinal MDR transport proteins and P-450 enzymes as barriers to oral drug delivery
3. Pharmacokinetics and effects of propranolol in terminal uraemic patients and in patients undergoing regular dialysis treatment
4. Pindolol availability in hypertensive patients with normal and impaired renal function
5. Influence of renal disease on pharmacokinetics
6. Pharmacokinetics of D-propoxyphene in anephric patient
7. Effects of intestinal and hepatic metabolism on the bioavailability of tacrolimus in rats
8. Reduced hepatic uptake of propranolol in rats with acute renal failure
9. Expression and function of P-glycoprotein in rats with glycerol-induced acute renal failure
10. Metabolism of tacrolimus (FK506) and its metabolite by rat liver microsomes
11. CYP1A2 and CYP2D6 4-hydroxylate propranolol and both reactions exhibit racial differences
12. Increased availability of propranolol in rats with uranyl nitrate-induced acute renal failure
13. Effect of experimental acute renal failure on intestinal barriers to drug absorption
14. Intestinal absorption of drugs in rats with glycerol-induced acute renal failure
15. Altered S-(-)-propranolol disposition in bilateral ureter-ligated rats
16. Decreased in vivo metabolism of drugs in chronic renal failure
17. Effect of intestinal P-glycoprotein on daily tacrolimus through level in a living-donor small bowel recipient
18. Pharmacokinetics and bioavailability of tacrolimus in rats with experimental renal dysfunction
19. Influence of glycerol-induced acute renal failure on the pharmacokinetics of cyclosporin in rats
20. Effects of experimental renal failure on the disposition kinetics of L-propranolol in rats
21. Reduced extraction of L-propranolol by perfused rat liver in the presence of uremic blood
22. Furosemide kinetics in renal failure
23. Clinical pharmacokinetics of tacrolimus
24. Pharmacokinetics and pharmacodynamics of FK506 in pediatric patients receiving living-related donor liver transplantations